What is the Kent Covid strain and why is it more contagious?
THE KENT variant of Covid-19 has mutated to escape immune responses and has been found in over 60 countries across the world.
Official reports today revealed that the variant could resist vaccines that are already in circulation.
🦠 Read our coronavirus live blog for the latest news & updates
So far 9.2 million Brits have received a first dose of their Covid jab, with nearly half a million having received their second.
Experts are now concerned that the Kent variant could get around vaccines.
The variant has been behind a surge in Covid-19 cases and hospitalisations since December 2020 - which forced the PM to tighten Christmas rules before placing England into a third national lockdown on January 5.
Public Health England (PHE) said that new data on the variant was "worrying".
The mutation, known as E484K, is already present in both South African and Brazilian coronavirus variants.
Laboratory studies have shown that antibodies are less able to bind to a part of the virus known as the spike protein, in order to stop it from unlocking human cells to gain entry.
It was previously thought this mutation was not present in the UK variant, also known as B.1.1.7.
But a recent report published by PHE said gene sequencing has shown that the E484K mutation has occurred spontaneously in only a handful of cases of the UK variant.
Where has the new strain of Covid come from?
The new strain's scientific name is VUI 2020/01, with VUI standing for Variant Under Investigation.
Essentially, the mutant strain's origins are still being probed by PHE's laboratories at Porton Down, Wiltshire.
Cases of the B.1.1.7 variant, or VOC 202012/01, have been reported in most of Europe, as well as in nations further afield including the US, Australia, India, China and Saudi Arabia.
In the US, the Centers for Disease Control and Prevention (CDC) said at least 122 cases had been identified in 20 states - with the bulk emerging in California and Florida.
Meanwhile, the new strain has been detected in Australia, Denmark, Gibraltar and Holland.
Will the Covid vaccine work against the Kent strain?
The COVID-19 vaccine developed by Pfizer and BioNTech appears to protect against B.1.1.7, according to results of a new study.
READ MORE SUN STORIES
In a study, researchers from BioNTech collected blood samples from 16 people who had received the in previous clinical trials.
They found that a lab-made version of the virus – with all the mutations resembling the B.1.1.7 variant – was neutralised by the volunteer’s immune system.